Current Status and Future Perspective of Rapid Diagnostic Kits Vaccine against COVID 19

Coronavirus disease 2019 COVID 19 , which causes serious respiratory illness such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei, China. The etiological agent of COVID 19 has been confirmed as a novel coronavirus, now known as severe acute respiratory syndrome coronavirus 2 SARS CoV 2 , which is most likely originated from zoonotic coronaviruses, like SARS CoV, which emerged in 2002. Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus 2019 nCoV outbreak. Currently, various diagnostic kits to test for COVID 19 are available and several repurposing therapeutics for COVID 19 have shown to be clinically effective. In addition, global institutions and companies have begun to develop vaccines for the prevention of COVID 19. Here, we review the current status of, diagnosis, and vaccine development for COVID 19. 

by M A Nandedkar | R A Shinde | S S Bansode ""Current Status and Future Perspective of Rapid Diagnostic Kits / Vaccine against COVID-19""

Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020,

URL: https://www.ijtsrd.com/papers/ijtsrd30977.pdf

Paper Url :https://www.ijtsrd.com/pharmacy/analytical-chemistry/30977/current-status-and-future-perspective-of-rapid-diagnostic-kits--vaccine-against-covid19/m-a-nandedkar

ugclistedjournals, indexedjournal, paperpublication